Suchergebnisse - "Magro, F"

PubPharm (45)

1

Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases : an International Organization for Study of Inflammatory Bowel Diseases consensus

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Ananthakrishnan, A. | Kaplan, G. | Bernstein, C. | +103

2

ECCO Position on Harmonisation of Crohn's Disease Mucosal Histopathology

enthalten in: Journal of Crohn's & colitis | 2022

von Magro, F. | Sabino, J. | Rosini, F. | +11

3

Microalgae consortia cultivation using effluents for bioproduct manufacture

enthalten in: Reviews in environmental science and bio-technology | 2021

von Magro, F. | Freitag, J. | Bergoli, A. | +2

4

Microalgae consortia cultivation using effluents for bioproduct manufacture

enthalten in: Reviews in environmental science and bio-technology | 2021

von Magro, F. | Freitag, J. | Bergoli, A. | +2

5

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2021

von Kucharzik, T. | Ellul, P. | Greuter, T. | +22

CommentIn: J Crohns Colitis. 2022 Jan 24;:. - PMID 35073577

6

Inflammatory Bowel Disease Management During the COVID-19 Outbreak : The Ten Do's and Don'ts from the ECCO-COVID Taskforce

enthalten in: Journal of Crohn's & colitis | 2020

von Magro, F. | Rahier, J. | Abreu, C. | +12

7

Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients : Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study

enthalten in: Journal of Crohn's & colitis | 2019

von Magro, F. | Lopes, S. | Silva, M. | +18

8

Editorial : antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Goncalves, J. | Magro, F. | Danese, S. | +2

CommentOn: Aliment Pharmacol Ther. 2018 Sep;48(5):507-522. - PMID 29873091

9

Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Goncalves, J. | Santos, M. | Acurcio, R. | +29

CommentIn: Aliment Pharmacol Ther. 2018 Sep;48(5):574-575. - PMID 30156324

10

Editorial : ulcerative colitis submucosal fibrosis and inflammation: more than just strictures

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Magro, F. | Sousa, H.

CommentOn: Aliment Pharmacol Ther. 2018 Apr;47(7):922-939. - PMID 29411405

1
2
3
4
5
Nächster »
[5]